125 related articles for article (PubMed ID: 7318122)
1. Phase II study of dibromodulcitol in colorectal, kidney, and other carcinomas.
Mischler NE; Tormey DC; Klotz J; Borden EC; Ramirez G; Banerjee TK; Carr RM; Zaentz SD; Graf J
Cancer Clin Trials; 1981; 4(4):407-10. PubMed ID: 7318122
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial.
Locker GY; Lanzotti V; Sweet D; Lad T; Khandekar J; Stiff P; Johnson C; Miller S
Cancer Treat Rep; 1984 Oct; 68(10):1303-4. PubMed ID: 6525605
[No Abstract] [Full Text] [Related]
3. Evaluation of adriamycin and dibromodulcitol in metastatic breast carcinoma.
Tormey DC; Simon R; Falkson G; Bull J; Band P; Perlin E; Blom J
Cancer Res; 1977 Feb; 37(2):529-34. PubMed ID: 832277
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an intermittent schedule of dibromodulcitol in breast cancer.
Tormey DC; Falkson G; Perlin E; Bull J; Blom J; Lippman ME
Cancer Treat Rep; 1976 Nov; 60(11):1593-6. PubMed ID: 1035505
[TBL] [Abstract][Full Text] [Related]
5. Positive phase II trial of dibromodulcitol in patients with metastatic melanoma refractory to DTIC and a nitrosourea.
Bellet RE; Catalano RB; Mastrangelo MJ; Berd D
Cancer Treat Rep; 1978 Dec; 62(12):2095-9. PubMed ID: 751717
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
Creagan ET; Ahmann DL; Schutt AJ; Green SJ
Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244
[TBL] [Abstract][Full Text] [Related]
7. Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
Michaelson R; Kemeny N; Young C
Cancer Treat Rep; 1982 Sep; 66(9):1757-8. PubMed ID: 6956441
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of fluorodopan in the treatment of advanced colorectal cancer.
Nair KG; Moayeri H; Mittelman A
Cancer Treat Rep; 1980; 64(4-5):697-99. PubMed ID: 7427955
[TBL] [Abstract][Full Text] [Related]
9. Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma.
Lynch G; Kemeny N; Casper E
Am J Clin Oncol; 1982 Oct; 5(5):541-3. PubMed ID: 7180833
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma.
Rubin J; van Hazel GA; Schutt AJ; Moertel CG; O'Connell MJ
Am J Clin Oncol; 1982 Oct; 5(5):539-40. PubMed ID: 7180832
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of dibromodulcitol (NSC-104800).
Andrews NC; Weiss AJ; Wilson W; Nealon T
Cancer Chemother Rep; 1974; 58(5 Pt 1):653-60. PubMed ID: 4426045
[No Abstract] [Full Text] [Related]
12. Phase II study of chlorozotocin in the treatment of advanced colorectal cancer.
Lawton JO; Giles GR; Hall J; MacAdam A; Hall R; Matheson T; Bird G
Cancer Treat Rep; 1981; 65(1-2):13-15. PubMed ID: 6452945
[TBL] [Abstract][Full Text] [Related]
13. [Phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in gastrointestinal cancer].
Takenaka K; Tamada R; Hiramoto Y; Inokuchi K; Saku M; Oka N; Kano T; Noda S; Nagasaki S; Toda T
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2155-60. PubMed ID: 4062315
[TBL] [Abstract][Full Text] [Related]
14. Vindesine in the treatment of advanced colorectal cancer: a phase II study.
Diaz-Rubio E; Martin-Jimenez M
Cancer Treat Rep; 1984 Mar; 68(3):555-6. PubMed ID: 6704985
[No Abstract] [Full Text] [Related]
15. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
[No Abstract] [Full Text] [Related]
16. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
[TBL] [Abstract][Full Text] [Related]
17. Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer.
Vogelzang NJ; Mani S; Schilsky RL; Ansari RH; Taber D; Rhinehart SN; Garcia JC; Meyer SC; Mick R; Brockstein BE; Stadler WM; Ratain MJ; Vokes EE
Clin Cancer Res; 1998 Apr; 4(4):929-34. PubMed ID: 9563886
[TBL] [Abstract][Full Text] [Related]
18. Preliminary experience with Mitolactol in advanced tumors of the orofacial region and the larynx.
Cichý A; Grobarcíková E; Klimo J; Jurga L; Pivonka M
Neoplasma; 1976; 23(4):427-34. PubMed ID: 1004654
[TBL] [Abstract][Full Text] [Related]
19. Phase II evaluation of metoprine in patients with advanced colorectal carcinoma.
Lynch G; Kemeny N; Currie V
Cancer Treat Rep; 1981; 65(1-2):127-8. PubMed ID: 7226162
[No Abstract] [Full Text] [Related]
20. Oral estramustine phosphate (Estracyt): a broad phase II study.
Halpern J; Catane R
J Med; 1984; 15(1):35-43. PubMed ID: 6593404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
